AbbVie Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable increased by 80.3% to -$81.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 121.4%, from $378.00M to -$81.00M. Over 2 years (FY 2021 to FY 2024), Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable shows a downward trend with a 58.9% CAGR.
An increase indicates tax deferral (positive for cash flow), while a decrease indicates a cash outflow to settle prior tax obligations.
This represents the change in the company's net tax liability, reflecting the timing difference between tax expense reco...
Standard line item in the operating section of the cash flow statement for all tax-paying entities.
operating_increase_decrease_in_income_taxes_payable_net__ad728c| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$753.00M | -$66.00M | -$662.00M | $438.00M | -$548.00M | $294.00M | $358.00M | $187.00M | -$1.12B | $378.00M | -$1.83B | $0.00 | -$1.80B | $378.00M | -$1.38B | -$411.00M | -$81.00M |
| QoQ Change | — | +91.2% | -903.0% | +166.2% | -225.1% | +153.6% | +21.8% | -47.8% | -698.4% | +133.8% | -585.2% | +100.0% | — | +121.0% | -463.8% | +70.1% | +80.3% |
| YoY Change | — | — | — | — | +27.2% | +545.5% | +154.1% | -57.3% | -104.2% | +102.1% | -63.9% | — | — | +0.0% | +25.0% | — | -121.4% |